Figure 2. Kaplan-Meier survival curve analysis showing progression-free survival ((A) GG vs GA vs AA, (C) GA+AA vs GG, (E) AA vs GA+GG) and overall survival (B) GG vs GA vs AA, (D) GA+AA vs GG, (F) AA vs GA+GG) of NSCLC patients with HIF1-alpha rs11549467.